89 related articles for article (PubMed ID: 18274862)
21. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
Minobe S; Todo Y; Suzuki Y; Aoyagi Y; Umazume T; Okamoto K; Kato H
J Obstet Gynaecol Res; 2011 Jun; 37(6):645-9. PubMed ID: 21375676
[TBL] [Abstract][Full Text] [Related]
22. Langerhans cell sarcoma of the nasopharynx: a rare case.
Keklik M; Sivgin S; Kontas O; Abdulrezzak U; Kaynar L; Cetin M
Scott Med J; 2013 Nov; 58(4):e17-20. PubMed ID: 24215052
[TBL] [Abstract][Full Text] [Related]
23. Dana-Farber Cancer Institute studies in advanced sarcoma.
Antman KH; Elias A
Semin Oncol; 1990 Feb; 17(1 Suppl 2):7-15. PubMed ID: 2106162
[TBL] [Abstract][Full Text] [Related]
24. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide.
Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696
[TBL] [Abstract][Full Text] [Related]
25. Ambulatory administration of 5-day infusion ifosfamide+mesna: a pilot study in sarcoma patients.
Coriat R; Mir O; Camps S; Ropert S; Billemont B; Leconte M; Larousserie F; Anract P; Alexandre J; Goldwasser F
Cancer Chemother Pharmacol; 2010 Feb; 65(3):491-5. PubMed ID: 19588140
[TBL] [Abstract][Full Text] [Related]
26. High-dose-intensity combination chemotherapy for advanced sarcomas: a pilot study.
Pronzato P; Losardo P; Pensa F; Tognoni A
Cancer Chemother Pharmacol; 1998; 41(6):513-6. PubMed ID: 9554597
[TBL] [Abstract][Full Text] [Related]
27. Crossover randomized comparison of intravenous versus intravenous/oral mesna in soft tissue sarcoma treated with high-dose ifosfamide.
Mace JR; Keohan ML; Bernardy H; Junge K; Niebch G; Romeis P; Thoma A; Wagner T; Mueller U; Demetri G; Baker LH
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5829-34. PubMed ID: 14676103
[TBL] [Abstract][Full Text] [Related]
28. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
Barişta I; Tekuzman G; Yalçin S; Güllü I; Güler N; Ozişik Y; Kars A; Celik I; Türker A; Altundağ K; Zengin N; Uner A; Baltali E; Firat D
J Surg Oncol; 2000 Jan; 73(1):12-6. PubMed ID: 10649272
[TBL] [Abstract][Full Text] [Related]
29. Langerhans cell sarcoma: a case report.
Valentín-Nogueras SM; Seijo-Montes R; Montalván-Miró E; Sánchez JL
J Cutan Pathol; 2013 Jul; 40(7):670-5. PubMed ID: 23590692
[TBL] [Abstract][Full Text] [Related]
30. Ifosfamide combination regimens for soft-tissue sarcoma.
Stuart-Harris R; Dalley D; Bell DR; Levi J; Simes RJ; Wiltshaw E
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S185-8. PubMed ID: 8453695
[TBL] [Abstract][Full Text] [Related]
31. Langerhans cell sarcoma.
Ferringer T; Banks PM; Metcalf JS
Am J Dermatopathol; 2006 Feb; 28(1):36-9. PubMed ID: 16456323
[TBL] [Abstract][Full Text] [Related]
32. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
33. Langerhans cell sarcoma: a case report and review of the literature.
Lee JY; Jung KE; Kim HS; Lee JY; Kim HO; Park YM
Int J Dermatol; 2014 Feb; 53(2):e84-7. PubMed ID: 23557341
[No Abstract] [Full Text] [Related]
34. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.
Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM
J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
[TBL] [Abstract][Full Text] [Related]
36. Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
Worden FP; Taylor JM; Biermann JS; Sondak VK; Leu KM; Chugh R; McGinn CJ; Zalupski MM; Baker LH
J Clin Oncol; 2005 Jan; 23(1):105-12. PubMed ID: 15625365
[TBL] [Abstract][Full Text] [Related]
37. Primary angiosarcoma of the ovary: a case report of Stage I disease.
Quesenberry CD; Li C; Chen AH; Zweizig SL; Ball HG
Gynecol Oncol; 2005 Oct; 99(1):218-21. PubMed ID: 16081151
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcoma. The Eastern Cooperative Oncology Group.
Blum RH; Edmonson J; Ryan L; Pelletier L
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S238-40. PubMed ID: 8453706
[TBL] [Abstract][Full Text] [Related]
39. Multidisciplinary management of metastatic sarcoma.
Thornton K; Pesce CE; Choti MA
Surg Clin North Am; 2008 Jun; 88(3):661-72, viii. PubMed ID: 18514705
[TBL] [Abstract][Full Text] [Related]
40. Retroperitoneal synovial sarcoma.
Domşa I; Crişan D; Olinici CD
Rom J Morphol Embryol; 2006; 47(2):187-91. PubMed ID: 17106529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
